Pfizer Q2 Results
- BSE: 500680
- NSE: PFIZER
- ISIN: INE182A01018
- Sector: Major Drugs
BSE
4,840.00
29.70 (0.62%)
29.70 (0.62%)Volume1.37 K
Updated: Fri 6 Mar, 2026 | 15:29:00
NSE
4,84539.00 (0.81%)
39.00 (0.81%)Volume8.66 K
Updated: Fri 6 Mar, 2026 | 15:30:04
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Pfizer Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 426.69 | 407.44 | 4.72% | 414.33 | 2.98% |
| Depreciation/ Amortization | 14.28 | 14.41 | -0.90% | 14.99 | -4.74% |
| Operating Income | 215.65 | 195.61 | 10.24% | 174.26 | 23.75% |
| Net Income | 189.02 | 191.75 | -1.42% | 158.35 | 19.37% |
| Other Operating Expenses Total | 89.79 | 85.98 | 4.43% | 87.86 | 2.20% |
| Net Income Before Taxes | 255.37 | 259.53 | -1.60% | 215.23 | 18.65% |
| Total Revenue | 642.34 | 603.05 | 6.52% | 588.59 | 9.13% |
| Selling/ General/ Admin Expenses Total | 94.67 | 95.82 | -1.20% | 100.76 | -6.04% |
| Diluted Normalized EPS | 41.32 | 41.91 | -1.41% | 34.61 | 19.39% |